The RRA outcomes after ComBat normalization was similar with that before normalization, and CD160 was still the most aberrantly expressed co-signaling molecule in autoimmune diseases (adjusted P-value = 1.3E-11, Supplementary Figure 3, Supplementary Table 4). Here, CD160 is linked to autoimmune disease.